Customer Service Chief Operating

Teresa M. Leezer

502-***-**** aduxp4@r.postjobfree.com https://linkedin.com/in/teresa-leezer

EDUCATION

• University of Louisville

o Masters of Business Administration (MBA)

o Bachelor of Applied Science (BAS), Scholars Program, summa cum laude

• City University, London - Scholars Program

• University of Oxford, England - Scholars Program LEADERSHIP

• University of Pennsylvania Wharton School of Business - Executive Leadership Development Program

• Columbia University School of Business - Strategic Marketing Development Program EXPERIENCE

Medical Transformation, Inc.

Chief Operating Officer 2020-Present

Medical Transformation is a scale up medical technology company pioneering The Cellular Approach™. Our medical centers offer the newest breakthroughs in health technology to maximize energy, strength, treat and prevent disease and extend health span. We deliver the most advanced tools, diagnostics and cellular solutions that Optimize Health.

• Increased revenue 180% year over year - Directed Strategic Development, Marketing and Operations - P&L, Strategic Planning, HIPAA, EHR, HR, First Aid, Commercial Lab, Database Development, CRM, Medicare, Social Media, SEO, SEM, Monday Project Management Software, Google Ads, SOPs, B2B, B2C, Customer Service, Protocols, Continuous Improvement, Standard Operating Procedures, SharePoint, Salesforce, Data Analytics, Recruiting, Contracting, and Team Development for First Mover Advantage to scale and launch a Medical Centers nationally.

• Launched new Cellular Technologies, increasing per patient revenue 160% - Designed each center to deliver the latest Cellular Solutions including First in Class global stem cell procedures, novel IV treatments, cutting edge PRP Protocols, innovative Regenerative Regimens, peptides and genetically driven solutions to Optimize Health. Leveraged integrated marketing platform through classic marketing channels, email marketing and social media.

• Increased Supplement Product Revenue 150% year over year - Launched Regenavita™ a national supplement platform company and Consumer APP with Lifestyle and Wellness Hacks. Proprietary solutions designed to leverage synergies and unique cellular protocols, creating wellbeing at the cellular level.

• Expanded Customer Base 150% year over year - Developed and Launched the Personal Transformation Plan™ tool – a personal milestone roadmap utilizing individual genetics, diagnostics and cellular profiles to motivate and guide patients on their journey toward Optimal Health. NeuroCures Foundation

President & Chief Executive Officer 2016-2020

NeuroCures is a foundation that funds groundbreaking science centered around the Halo Effect™, a domino matrix within degenerative diseases – once you discover the key to one, you uncover vital clues to cure another.

• Founded and Developed non-profit and Raised $5M in donations and $4M in grants to advance cures and clinical care solutions from bench to bedside. Developed and executed internal and external Strategies. Optimized marketing and media management across all channels including social media.

• Developed consultative donor strategy to increase donor network and engagement. Created fundraising storyline to help investors understand how we leverage novel stem cell, nanotechnology and biotech tools to find cures for diseases such as Multiples Sclerosis, Spinal Cord Injuries, Alzheimer’s and Parkinson’s Disease.

• Raised $2M in grant funding for groundbreaking research. Managed a translational research team of ten cross- functional teammates to accelerate clinical findings and solutions for use in clinical practice. RhinoCyte, Inc.

President & Chief Executive Officer 2010-2016

Agile Strategic Development Professional with 20 years of experience building cohesive brands, operations and cultures at Fortune 100 companies like Bristol Myers Squibb to NASDAQ, start-up and scale-ups Expertise: Strategic Development, Digital Marketing, Branding, Marketing, Corporate Communications, Operations, P&L, Product Management & Development, Acquisitions & Strategic Forecasting, Business Development, Sales Management, Team Leadership, Consumer Health App, Partnerships, B2B, B2C Established novel adult stem cell start-up, targeting cures for neurological diseases to extend and enhance human life.

• Raised $10 Million through Development Efforts to deliver first in class transformational stem cell technology platform to treat Spinal Cord Injuries, Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, and ALS

(Lou Gehrig’s Disease). Engineered strategic communication and to increase national and global presence.

• Established quality and LEAN manufacturing standards, Budgeting, Pre-IND, Technology Validation, P&L, Management, Quality, OSHA safety guidelines and hazardous waste disposal programs leveraged throughout cross functional teams to meet FDA regulations for innovative Phase I/IIA Clinical Trial Model for Spinal Cord Injury that delivered results in half the time of established trial benchmarks.

• Established new process controls for standardization and communication for adult cell products cGMP manufacturing. Directed lab staff and development to meet regulatory timelines for FDA approval.

• Developed strategic forecasting and analytics to determine first mover advantage, competitive landscape SWOT and financial modeling for product and portfolio development. MetaCyte Business Lab

Vice President 2007-2010

MetaCyte is an accelerator created to Partner with Bucks for Brains faculty at the University of Louisville and University of Kentucky to create viable technology/medical start-ups by leveraging strategic planning, mentorship and financing.

• Raised $20 Million through development strategies in growth and angel capital translating to $400 Million in portfolio assets over tenure.

• Led company creation, fundraising, business development, communication of brand strategy and capital investment for twenty biomedical therapies and devices, including scheduled compounds.

• Created first in class product opportunities by establishing innovative global intellectual property protection.

• Developed strategic plans, forecasting and analytics to drive development of therapies to leverage first mover advantage, competitive landscape SWOT and financial modeling for product development and launch. Delor

Vice President 2004-2006

Delor is a creative agency that focuses on brand storytelling and creation for clients mostly in the healthcare industry.

• Led corporate branding, marketing, product positioning, and B2B business development to drive opportunities for Fortune 100 pharmaceutical and healthcare companies.

• Developed overarching brand strategy and positioning for Eli Lilly and Company, Proctor and Gamble Company and Tercica, Inc., leveraging market and competitive analysis, and qualitative and quantitative market research.

• Developed strategic and business development plans yielding double digit growth of 115% versus sales goal.

• Drove new business for Prozac and Humalog strategic positioning in key accounts resulting in significant market response of 120% versus goal.

Bristol-Myers Squibb Company

Executive Director 2001-2004

Led commercialization and competitive strategies for portfolio assets through compelling and consistent branding and messaging across Antibiotic, Oncology, Antifungal and HIV portfolio assets in hospital, physician office and OTC.

• Led the most successful launch in the company’s history – Sustiva and Reyataz, first in class once daily global HIV therapies, exceeding target sales by 120% and 130% respectively

• Directed global launch matrix team, Phase IIIB Clinical Trials, Branding, Product Management, Marketing, Salesforce, Qualitative and Quantitative Research, Logistics, Manufacturing, IT, Training, Financial Analysis and Business Units for flawless execution and 119% of sales versus goal.

• Exceeded Franchise Sales Goals by 125% year over year growth. Directed key strategies leveraging key KPIs, qualitative and quantitative market research for the oncology and virology portfolio including: Taxol, Paraplatin, Sustiva, Reyataz and Erbitux.

BOARDS

AllTranz/Zenerba, Inc. – Director/Board Member (2007-2015) Cannabidiol technology start-up, $250M NASDAQ IPO Ronald McDonald House – Board of Directors 2012-2018 St. Francis of Assisi – Parish Council Board Chair 2016-2019; School Board Chair 2013-2016; Strategic Plan Chair 2013, 2018; Parent Volunteer Organization Board Chair 2016, 2017 VOLUNTEER

Catholic Charities – Refugee Language Services Tutor St. Xavier - Swim Team Stroke and Turn Judge 2019–present; Parent Council 2019-2020 Habitat for Humanity – Stable Homes and Neighborhoods Program 2018-2019 Boy Scout Troop 40 - Charter Director 2015-2019

Contact this candidate